POSACONAZOLE
NDC 0254-1016, posaconazole, suspension, from ENDO USA, Inc..
- Product NDC
- 0254-1016
- Status
- Listed
- Labeler
- ENDO USA, Inc.
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA022003
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0254-1016 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- POSACONAZOLE40 mg/mL
Pharmacologic classes
Azole Antifungal [EPC]; Azoles [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0254-1016-36 | 00254101636 | 1 BOTTLE, GLASS in 1 CARTON (0254-1016-36) / 105 mL in 1 BOTTLE, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e031b632-8e57-4359-87bd-a5da02bdc55f
Use it
Look up 0254-1016 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0254-1016 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0254-1016. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.